TF and cancer: The reason for targeting TF by fVII was that TF is selectively expressed by angiogenic VECs and overexpressed by many types of cancer cells (Contrino et al, 1996; Hu et al, 1999; Hu and Garen, 2001; Tang et al, 2007).